WeGo Y 1.5mg is NOT the same as Rybelsus (semaglutide)
I cannot identify "WeGo Y 1.5mg" as an FDA-approved medication or recognized pharmaceutical product in any of the available evidence, guidelines, or drug labels provided.
What is Rybelsus?
Rybelsus is the brand name for oral semaglutide, a GLP-1 receptor agonist FDA-approved for type 2 diabetes treatment. 1, 2
- Rybelsus is available in tablet strengths of 3mg, 7mg, and 14mg for once-daily oral administration 1
- The maximum approved daily dose is 14mg 1
- Oral semaglutide (Rybelsus) is FDA-approved only for type 2 diabetes treatment, NOT for obesity management 2
Critical Safety Concern
If "WeGo Y" is being marketed as equivalent to Rybelsus or semaglutide, this raises serious red flags about counterfeit or unapproved medications. The FDA has not approved any product by this name, and using non-FDA-approved versions of semaglutide poses significant safety risks including:
- Unknown purity and potency
- Potential contamination
- Incorrect dosing
- Lack of quality control
- Risk of serious adverse events including pancreatitis, gallbladder disease, and thyroid tumors 2, 3
Legitimate Semaglutide Formulations
The only FDA-approved semaglutide products are:
- Rybelsus (oral): 3mg, 7mg, 14mg tablets for type 2 diabetes 1, 2
- Ozempic (injectable): 0.25mg, 0.5mg, 1mg weekly for type 2 diabetes 4
- Wegovy (injectable): up to 2.4mg weekly for obesity management 2, 5
Recommendation
Do not use "WeGo Y 1.5mg" as a substitute for Rybelsus. If you have been prescribed semaglutide, obtain it only through legitimate pharmacies with a valid prescription for FDA-approved formulations. If cost is a barrier, discuss with your healthcare provider about patient assistance programs or alternative medications. 2